Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentra Group Holdings Parent (CON) Change in Cash (2023 - 2026)

Concentra Group Holdings Parent (CON) reported Change in Cash of -$18.2 million for Q1 2026, up 86.12% year-over-year from -$9.8 million in Q1 2025, and down 160.75% on a QoQ basis from $30.0 million in Q4 2025.

Concentra Group Holdings Parent (CON) has 4 years of Change in Cash data on file, last reported at -$18.2 million in Q1 2026.

  • Quarterly Change in Cash rose 86.12% year-over-year to -$18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 275.05% YoY) and the FY2025 annual result came in at -$103.4 million, down 168.05% from the prior year.
  • Change in Cash declined to -$18.2 million in Q1 2026 per CON's latest filing, from $30.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $86.2 million in Q3 2024 and bottomed at -$131.1 million in Q1 2025.
  • The 4-year median for Change in Cash is $7.7 million (2023), against an average of $2.6 million.
  • Peak annual rise in Change in Cash reached 1848.34% in 2025, while the deepest fall reached 821.45% in 2025.
  • Tracing CON's Change in Cash over 4 years: stood at $7.7 million in 2023, then soared by 503.5% to $46.4 million in 2024, then slumped by 35.48% to $30.0 million in 2025, then tumbled by 160.75% to -$18.2 million in 2026.
  • Per Business Quant, the three latest CON Change in Cash figures stand at -$18.2 million (Q1 2026), $30.0 million (Q4 2025), and -$23.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -100.00 Mn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 84.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -31.34 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 60.50 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 35.62 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -18.77 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn 399.14 Mn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn -57.66 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn 41.66 Mn
10 Concentra Group Holdings Parent 3.13 Bn 3.07 Bn 170.47 Mn -18.20 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.20 Mn
Dec 31, 2025 29.96 Mn
Sep 30, 2025 -23.93 Mn
Jun 30, 2025 21.76 Mn
Mar 31, 2025 -131.15 Mn
Dec 31, 2024 46.43 Mn
Sep 30, 2024 86.15 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 18.18 Mn
Dec 31, 2023 7.69 Mn
Sep 30, 2023 -9.56 Mn